UC-San Diego: Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation
June 10, 2021
June 10, 2021
LA JOLLA, California, June 10 (TNSJou) -- The University of California San Diego campus issued the following news release:
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
Metformin works by lowering glucose production in the liver, reducing blood sugar levels that, in turn, improve the body's response to in . . .
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
Metformin works by lowering glucose production in the liver, reducing blood sugar levels that, in turn, improve the body's response to in . . .